Clinical Trial Update: Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Pegasys (pegylated interferon alfa-2a) plus ribavirin in hemophilic patients with hepatitis C has completed. The document notes compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia
• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: Baqiyatallah Medical Sciences University | Conditions: Hepatitis C, Hemophilia | Phase 4 | Status: COMPLETED